Skystar Bio-Pharmaceutical Company financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2014-09-30 3 months ending 2014-06-30 3 months ending 2014-03-31 3 months ending 2013-12-31 3 months ending 2013-09-30
Revenue 18.35 14.24 6.83 9.63 15.99
Other Revenue, Total - - - - -
Total Revenue 18.35 14.24 6.83 9.63 15.99
Cost of Revenue, Total 9.59 7.88 4.01 4.91 7.78
Gross Profit 8.76 6.36 2.82 4.72 8.21
Selling/General/Admin. Expenses, Total 2.98 2.19 1.65 1.52 3.15
Research & Development 0.38 0.80 0.00 0.54 0.32
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) - - - - -
Other Operating Expenses, Total - - - - -
Total Operating Expense 12.95 10.87 5.66 6.97 11.25
Operating Income 5.40 3.37 1.17 2.66 4.74
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net 0.00 0.02 0.15 0.02 0.03
Income Before Tax 5.62 3.49 1.41 2.93 4.52
Income After Tax 4.91 2.81 0.98 2.33 3.73
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items 4.91 2.81 0.98 2.33 3.73
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income 4.91 2.81 0.98 2.33 3.73
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items 4.91 2.81 0.98 2.33 3.73
Income Available to Common Incl. Extra Items 4.91 2.81 0.98 2.33 3.73
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - 0.00 - -
Diluted Weighted Average Shares 8.57 7.80 7.70 7.78 7.62
Diluted EPS Excluding Extraordinary Items 0.57 0.36 0.13 0.30 0.49
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS 0.57 0.36 0.13 0.30 0.49